Cargando…

Glucose as the Fifth Vital Sign: A Randomized Controlled Trial of Continuous Glucose Monitoring in a Non-ICU Hospital Setting

OBJECTIVE: The current standard for hospital glucose management is point-of-care (POC) testing. We conducted a randomized controlled trial of real-time continuous glucose monitoring (RT-CGM) compared with POC in a non–intensive care unit (ICU) hospital setting. RESEARCH DESIGN AND METHODS: A total o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fortmann, Addie L., Spierling Bagsic, Samantha R., Talavera, Laura, Garcia, Isabel Maria, Sandoval, Haley, Hottinger, Amiry, Philis-Tsimikas, Athena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2020
Materias:	Novel Communications in Diabetes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576427/ https://www.ncbi.nlm.nih.gov/pubmed/32855160 http://dx.doi.org/10.2337/dc20-1016

Ejemplares similares

Mi Puente (My Bridge) Care Transitions Program for Hispanic/Latino Adults with Multimorbidity: Results of a Randomized Controlled Trial
por: Gallo, Linda C., et al.
Publicado: (2023)

Remote Continuous Glucose Monitoring With a Computerized Insulin Infusion Protocol for Critically Ill Patients in a COVID-19 Medical ICU: Proof of Concept
por: Davis, Georgia M., et al.
Publicado: (2021)

Fasting Blood Glucose and COVID-19 Severity: Nonlinearity Matters
por: Alahmad, Barrak, et al.
Publicado: (2020)

Corneal Confocal Microscopy Detects Neuropathy in Subjects With Impaired Glucose Tolerance
por: Asghar, Omar, et al.
Publicado: (2014)

Continuous Glucose Monitoring in the Intensive Care Unit During the COVID-19 Pandemic
por: Agarwal, Shivani, et al.
Publicado: (2021)

Early Hyperglycemia Detected by Continuous Glucose Monitoring in Children at Risk for Type 1 Diabetes
por: Steck, Andrea K., et al.
Publicado: (2014)

Plasma Glycated CD59, a Novel Biomarker for Detection of Pregnancy-Induced Glucose Intolerance
por: Ghosh, Pamela, et al.
Publicado: (2017)

Dulce Wireless Tijuana: A Randomized Control Trial Evaluating the Impact of Project Dulce and Short-Term Mobile Technology on Glycemic Control in a Family Medicine Clinic in Northern Mexico
por: Anzaldo-Campos, María Cecilia, et al.
Publicado: (2016)

Real-Time Continuous Glucose Monitoring Significantly Reduces Severe Hypoglycemia in Hypoglycemia-Unaware Patients With Type 1 Diabetes
por: Choudhary, Pratik, et al.
Publicado: (2013)

My Bridge (Mi Puente), a care transitions intervention for Hispanics/Latinos with multimorbidity and behavioral health concerns: protocol for a randomized controlled trial
por: Gallo, Linda C., et al.
Publicado: (2020)

Oral Glucose Tolerance Test Predicts Episodic Memory Decline: A 10-Year Population-Based Follow-up Study
por: Toppala, Sini, et al.
Publicado: (2021)

Peer-Led Diabetes Education Programs in High-Risk Mexican Americans Improve Glycemic Control Compared With Standard Approaches: A Project Dulce promotora randomized trial
por: Philis-Tsimikas, Athena, et al.
Publicado: (2011)

Tolerability, safety and adherence to treatment with insulin detemir injection in the treatment of type 2 diabetes
por: Philis-Tsimikas, Athena
Publicado: (2008)

Prescribing Narcotics for Pain: Reconsider the Fifth Vital Sign
por: Charles, Ronald A., et al.
Publicado: (2022)

Dulce Digital-Me: protocol for a randomized controlled trial of an adaptive mHealth intervention for underserved Hispanics with diabetes
por: Philis-Tsimikas, Athena, et al.
Publicado: (2022)

Acute Postoperative Pain in Trauma Patients - The Fifth Vital Sign
por: Farčić, Nikolina, et al.
Publicado: (2017)

Self-measurement of Blood Glucose and Continuous Glucose Monitoring – Is There Only One Future?
por: Heinemann, Lutz, et al.
Publicado: (2018)

Periodic Intensive Insulin Therapy Remains Experimental
por: Chang, Amy, et al.
Publicado: (2019)

A Fixed Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) Reduces Glycemic Fluctuation and Brings More Patients with Type 2 Diabetes Within Blood Glucose Target Ranges
por: King, Allen B., et al.
Publicado: (2017)

Sensor-augmented CSII therapy with predictive low-glucose suspend following total pancreatectomy
por: Scott, E S, et al.
Publicado: (2017)

Evaluation of Pain as A Fifth Vital Sign: Nurses' Opinions and Beliefs
por: Kutlutürkan, Sevinç, et al.
Publicado: (2019)

Denosumab improves glucose parameters in patients with impaired glucose tolerance: a systematic review and meta-analysis
por: Pacheco-Soto, Blanca T., et al.
Publicado: (2021)

The Rationale for Continuous Glucose Monitoring-based Diabetes Treatment Decisions and Non-adjunctive Continuous Glucose Monitoring Use
por: Price, David, et al.
Publicado: (2016)

Effect of Body Lotions on Capillary Blood Glucose Measurement – Interference of Hydroquinone-Containing Body Lotion with Capillary Glucose Measurement
por: Omengue, Andrea MA, et al.
Publicado: (2018)

Impact of Real-Time Continuous Glucose Monitoring Data Sharing on Quality of Life and Health Outcomes in Adults with Type 1 Diabetes
por: Polonsky, William H., et al.
Publicado: (2021)

Digital health tools to promote diabetes education and management of cardiovascular risk factors among under-resourced populations
por: Paul, Tenes, et al.
Publicado: (2021)

Continuous glucose monitoring in the management of patients after gastric bypass
por: Rodríguez Flores, Marcela, et al.
Publicado: (2019)

Insulin degludec overdose in an adolescent with type 1 diabetes: proactive management including monitoring using the Freestyle Libre flash glucose monitoring system
por: Thompson, Harmony, et al.
Publicado: (2018)

Vital Signs Prediction for COVID-19 Patients in ICU
por: Youssef Ali Amer, Ahmed, et al.
Publicado: (2021)

The fifth vital sign? Nurse worry predicts inpatient deterioration within 24 hours
por: Romero-Brufau, Santiago, et al.
Publicado: (2019)

Pain as the fifth vital sign—A comparison between public and private healthcare systems
por: Pozza, Daniel Humberto, et al.
Publicado: (2021)

Current Application of Continuous Glucose Monitoring in the Treatment of Diabetes: Pros and cons
por: Hermanides, Jeroen, et al.
Publicado: (2011)

Selecting the Appropriate Continuous Glucose Monitoring System – a Practical Approach
por: Adolfsson, Peter, et al.
Publicado: (2018)

Evolution of Abnormal Plasma Glucagon Responses to Mixed-Meal Feedings in Youth With Type 1 Diabetes During the First 2 Years After Diagnosis
por: Sherr, Jennifer, et al.
Publicado: (2014)

Novel Use and Utility of Integrated Electronic Health Records to Assess Rates of Prediabetes Recognition and Treatment: Brief Report From an Integrated Electronic Health Records Pilot Study
por: Schmittdiel, Julie A., et al.
Publicado: (2014)

Early Childhood Gut Microbiomes Show Strong Geographic Differences Among Subjects at High Risk for Type 1 Diabetes
por: Kemppainen, Kaisa M., et al.
Publicado: (2015)

Testing for Rewards: A Pilot Study to Improve Type 1 Diabetes Management in Adolescents
por: Petry, Nancy M., et al.
Publicado: (2015)

Impact of Lowering BMI Cut Points as Recommended in the Revised American Diabetes Association's Standards of Medical Care in Diabetes—2015 on Diabetes Screening in Asian Americans
por: Hsia, Daniel S., et al.
Publicado: (2015)

Excess BMI in Childhood: A Modifiable Risk Factor for Type 1 Diabetes Development?
por: Ferrara, Christine Therese, et al.
Publicado: (2017)

Anti–PD-1 Therapy–Associated Type 1 Diabetes in a Pediatric Patient With Relapsed Classical Hodgkin Lymphoma
por: Samoa, Raynald A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ir87s4rg5gjfu6qfpp1p0563js